Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.51 |
| ▸ | MAP4K4 | O95819 | 4/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.43 |
| ▸ | KCNK3 | O14649 | 4/20 | 0.40 |
| ▸ | KCNK9 | Q9NPC2 | 4/20 | 0.40 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | RET | P07949 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30127515 | 1.00 | GRM2 (0.51) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL30126083 | 0.92 | PARP1 (0.57) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL30126957 | 0.89 | GRM2 (0.52) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL30126214 | 0.89 | GRM2 (0.52) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL30125890 | 0.81 | PARP1 (0.58) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL31257591 | 0.80 | MAP4K4 (0.52) | MAP4K4PARP1GPR119RET | |
| SCHEMBL31257479 | 0.80 | MAP4K4 (0.52) | MAP4K4PARP1GPR119RET | |
| SCHEMBL30126182 | 0.79 | PARP1 (0.55) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL30127222 | 0.78 | PARP1 (0.54) | GRM2MAP4K4HDAC1PARP1GPR119 | |
| SCHEMBL31257541 | 0.78 | MAP4K4 (0.52) | MAP4K4HDAC1PARP1GPR119RET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022266458-A1 | 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |